Your browser doesn't support javascript.
loading
Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy.
Bisogno, Gianni; Fuchs, Joerg; Dasgupta, Roshni; Ferrari, Andrea; Haduong, Josephine H; Rogers, Timothy; Walterhouse, David O; Coppadoro, Beatrice; Xue, Wei; Vokuhl, Christian; Hawkins, Douglas S; Seitz, Guido; Merks, Johannes H M; Sparber-Sauer, Monika; Venkatramani, Rajkumar.
Afiliação
  • Bisogno G; Hematology Oncology Division, Department of Women's and Children's Health, University of Padova, Padova, Italy.
  • Fuchs J; Department of Pediatric Surgery and Urology, University Children's Hospital, Tuebingen, Germany.
  • Dasgupta R; Cincinnati Children's Hospital Medical Center, Division of Pediatric General and Thoracic Surgery, University of Cincinnati, Cincinnati, Ohio, USA.
  • Ferrari A; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Haduong JH; Hyundai Cancer Institute, Division of Oncology, Children's Hospital Orange County, Orange, California, USA.
  • Rogers T; Department of Pediatric Surgery, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Walterhouse DO; Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Coppadoro B; Hematology Oncology Division, Department of Women's and Children's Health, University of Padova, Padova, Italy.
  • Xue W; Department of Biostatistics, University of Florida, Gainesville, Florida, USA.
  • Vokuhl C; Section of Pediatric Pathology, Department of Pathology, University Hospital Bonn, Bonn, Germany.
  • Hawkins DS; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
  • Seitz G; Department of Pediatric Surgery and Urology, University Hospital Giessen-Marburg, Campus Marburg, Marburg, Germany.
  • Merks JHM; Princess Màxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Sparber-Sauer M; Klinikum der Landeshauptstadt Stuttgart gKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), Stuttgart, Germany.
  • Venkatramani R; University of Medicine Tübingen, Tübingen, Germany.
Cancer ; 128(23): 4150-4156, 2022 12 01.
Article em En | MEDLINE | ID: mdl-36250420
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Rabdomiossarcoma Embrionário Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Rabdomiossarcoma Embrionário Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article